{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:29:18Z","timestamp":1771561758023,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["2780\/2021"],"award-info":[{"award-number":["2780\/2021"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RF- 2019-12369782"],"award-info":[{"award-number":["RF- 2019-12369782"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ymgme.2025.109088","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:06:49Z","timestamp":1742184409000},"page":"109088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The clinical value of peripheral biogenic amine metabolites in early-treated phenylketonuria"],"prefix":"10.1016","volume":"145","author":[{"given":"Filippo","family":"Manti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Di Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Santagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Giovanniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Angeloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Pascucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Nardecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Carducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109088_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymgme.2025.109088_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2019-106278","article-title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines","volume":"57","author":"Leuzzi","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109088_bb0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00001756-200004270-00042","article-title":"Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria","volume":"11","author":"Puglisi-Allegra","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.ymgme.2025.109088_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0084697","article-title":"Behavioral and neurochemical characterization of new mouse model of Hyperphenylalaninemia","volume":"8","author":"Pascucci","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109088_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00491918","article-title":"Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents","volume":"144","author":"Lou","year":"1985","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109088_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1005694122277","article-title":"Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment","volume":"23","author":"Burlina","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109088_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/jimd.12049","article-title":"Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria","volume":"42","author":"Pilotto","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109088_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","article-title":"Monoamine neurotransmitter disorders - clinical advances and future perspectives","volume":"11","author":"Ng","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1017\/S1461145709990381","article-title":"5-Hydroxytryptophan rescues serotonin response to stress in prefrontal cortex of hyperphenylalaninaemic mice","volume":"12","author":"Pascucci","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S1461145710001288","article-title":"5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria","volume":"14","author":"Andolina","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2017.10.009","article-title":"Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice","volume":"123","author":"Winna","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109088_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10286-010-0065-7","article-title":"Catecholamines 101","volume":"20","author":"Goldstein","year":"2010","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.ymgme.2025.109088_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrgastro.2013.105","article-title":"Serotonin signaling in the gastrointestinal tract: functions, dysfunctions, and therapeutic targets","volume":"10","author":"Mawe","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/en.2016-1839","article-title":"The diverse metabolic roles of peripheral serotonin","volume":"158","author":"Martin","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymgme.2025.109088_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cca.2017.04.001","article-title":"A serum and platelet-rich plasma serotonin assay using liquid chromatography-tandem mass spectrometry to monitor neuroendocrine tumor patients","volume":"469","author":"Korse","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109088_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2018.03.030","article-title":"Comparison of serum serotonin and serum 5-HIAA LC-MS\/MS assays in the diagnosis of serotonin producing neuroendocrine neoplasms: a pilot study","volume":"482","author":"Lindstr\u00f6m","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109088_bb0085","series-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM)","author":"Bioanalytical Method Validation Guidance for Industry","year":"2018"},{"key":"10.1016\/j.ymgme.2025.109088_bb0090","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.ymgme.2025.109088_bb0095","series-title":"Wechsler Adult Intelligence Scale- Revised (WAIS-R), New York, The Psychological Corporation, 1981. Italian version, C. Laicardi, A. Orsini, Scala di intelligenza Wechsler per adulti, Organizzazioni Speciali, Firenze","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.ymgme.2025.109088_bb0100","series-title":"Wechsler Adult Intelligence Scale- Fourth Edition (WAIS-IV), San Antonio, Pearson Assessment, 2008. Italian version, A. Orsini, L. Pezzuti, Scala di intelligenza Wechsler per adulti - quarta edizione, Giunti Psychometrics, Firenze","author":"Wechsler","year":"2013"},{"key":"10.1016\/j.ymgme.2025.109088_bb0105","series-title":"BRIEF2: Behavior Rating Inventory of Executive Function","author":"Gioia","year":"2015"},{"key":"10.1016\/j.ymgme.2025.109088_bb0110","series-title":"Behavior Rating Inventory of Executive Function\u2014Adult Version","author":"Roth","year":"2005"},{"key":"10.1016\/j.ymgme.2025.109088_bb0115","series-title":"Manual for the ASEBA School-Age Forms and Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, and Families, 1991. Italian version, Frigerio A","author":"Achenbach","year":"2001"},{"key":"10.1016\/j.ymgme.2025.109088_bb0120","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1210\/er.2018-00283","article-title":"Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule","volume":"40","author":"Yabut","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymgme.2025.109088_bb0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/mi.10.4.6","article-title":"Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels","volume":"10","author":"Mercado","year":"2010","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ymgme.2025.109088_bb0130","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199000163-00002","article-title":"Origin and metabolism of serotonin","volume":"16","author":"Tyce","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3324\/haematol.2014.106260","article-title":"Platelet count and aging","volume":"99","author":"Balduini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ymgme.2025.109088_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts in the united state differ by sex, ethnicity, and age","volume":"16","author":"Segal","year":"2006","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10545-005-0153-3","article-title":"Platelet serotonin concentrations in PKU patients under dietary control and tetrahydrobiopterin treatment","volume":"28","author":"Ormazabal","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109088_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2014.03.061","article-title":"Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation","volume":"165","author":"Yano","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109088_bb0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejpn.2019.08.005","article-title":"Prevalence of sleep disorders in early-treated phenylketonuric children and adolescents. Correlation with dopamine and serotonin status","volume":"23","author":"Gassio","year":"2019","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2025.109088_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgmr.2018.03.008","article-title":"Salivary serotonin does not correlate with central serotonin turnover in adult phenylketonuria (PKU) patients","volume":"15","author":"Leung","year":"2018","journal-title":"Mol. Genet. Metab. Report."},{"key":"10.1016\/j.ymgme.2025.109088_bb0165","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1017\/S0033291717001398","article-title":"Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria","volume":"47","author":"Boot","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ymgme.2025.109088_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s42000-020-00176-z","article-title":"Metabolic and catecholamine response to sympathetic stimulation in early-treated adult male patients with phenylketonuria","volume":"19","author":"Sumanszki","year":"2020","journal-title":"Hormones"},{"key":"10.1016\/j.ymgme.2025.109088_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108580","article-title":"Pegvaliase treatment normalizes blood neurotransmitter metabolites in adults with phenylketonuria","volume":"143","author":"Sigg","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109088_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107666","article-title":"Towards precision medicine for phenylketonuria: the effect of restoring a strict metabolic control in adult patients with early-treated phenylketonuria","volume":"140","author":"Manti","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109088_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2019-106278","article-title":"Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines","volume":"57","author":"Leuzzi","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109088_bb0190","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1037\/neu0000942","article-title":"The relationship between working memory and anxiety in individuals with early treated phenylketonuria (PKU)","volume":"38","author":"Boland","year":"2024","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ymgme.2025.109088_bb0195","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1037\/neu0000625","article-title":"Executive function in phenylketonuria (PKU): insights from the behavior rating inventory of executive function (BRIEF) and a large sample of individuals with PKU","volume":"34","author":"Christ","year":"2020","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ymgme.2025.109088_bb0200","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ymgme.2009.10.006","article-title":"Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic","volume":"99","author":"Waisbren","year":"2010","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:40:18Z","timestamp":1771558818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1096719225000794"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109088","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical value of peripheral biogenic amine metabolites in early-treated phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109088"}}